Intraday Alerts
FONT-SIZE Plus   Neg

Achillion Pharmaceuticals Inc. (ACHN) Has Jumped To A 5-Month High

Trade ACHN now with 

Deutsche Bank initiated coverage of Achillion Pharmaceuticals Inc. (ACHN: Quote) Wednesday morning, with a "Buy" rating.

Achillion Pharmaceuticals has gapped open sharply higher this morning and is now up 1.42 at $9.52 on above average volume. The stock has been rising for over a month and has set a 5-month high.

Click here to receive FREE breaking news email alerts for Achillion Pharmaceuticals Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback:

Business News

comments powered by Disqus